Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study
Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing ri...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 81; no. 4; pp. 851 - 860 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Lippincott Williams & Wilkins
01.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers.
Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years.
Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [
<0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [
<0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% (
<0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring (
<0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1,
=0.003) and insulin resistance.
After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia. |
---|---|
AbstractList | BACKGROUND:
Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers.
METHODS:
Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years.
RESULTS:
Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [
P
<0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [
P
<0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% (
P
<0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring (
P
<0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1,
P
=0.003) and insulin resistance.
CONCLUSIONS:
After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia. Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers. Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years. Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [ <0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [ <0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% ( <0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring ( <0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, =0.003) and insulin resistance. After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia. BACKGROUNDIncreased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers.METHODSSix months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years.RESULTSTwo years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [P<0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [P<0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% (P<0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring (P<0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, P=0.003) and insulin resistance.CONCLUSIONSAfter preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia. |
Author | Pettit, Franziska Youssef, George Mangos, George Crowley, Rose Henry, Amanda Brown, Mark A Roberts, Lynne M Davis, Gregory K O'Sullivan, Anthony J |
Author_xml | – sequence: 1 givenname: Amanda orcidid: 0000-0002-7351-8922 surname: Henry fullname: Henry, Amanda organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.) – sequence: 2 givenname: George surname: Mangos fullname: Mangos, George organization: Departments of Renal Medicine (G.M., M.A.B., F.P.) – sequence: 3 givenname: Lynne M orcidid: 0000-0003-2339-3751 surname: Roberts fullname: Roberts, Lynne M organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.) – sequence: 4 givenname: Mark A orcidid: 0000-0002-4759-9407 surname: Brown fullname: Brown, Mark A organization: Departments of Renal Medicine (G.M., M.A.B., F.P.) – sequence: 5 givenname: Franziska surname: Pettit fullname: Pettit, Franziska organization: Departments of Renal Medicine (G.M., M.A.B., F.P.) – sequence: 6 givenname: Anthony J surname: O'Sullivan fullname: O'Sullivan, Anthony J organization: Endocrinology (A.J.O.), St George Hospital, Kogarah, Australia – sequence: 7 givenname: Rose surname: Crowley fullname: Crowley, Rose organization: Cardiology (R.C., G.Y.) St George Hospital, Sydney, Australia – sequence: 8 givenname: George orcidid: 0000-0003-0579-1975 surname: Youssef fullname: Youssef, George organization: Cardiology (R.C., G.Y.) St George Hospital, Sydney, Australia – sequence: 9 givenname: Gregory K surname: Davis fullname: Davis, Gregory K organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38288610$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkV9P2zAUxS3ENArsKyDzxks6X9tx7L2gqCorEoMKOmk8Wa7j0IzULnaC1G-_jH8Cnq507znnHum3j3Z98A6hYyBjAAHfZ7fz6fVienlzfnVZzsoxUDamIBXZQSPIKc94LtguGhFQPFMAf_bQfkp_CQHOefEV7TFJpRRARqieR-dsa9ab1JisTCnYxnSuwhMTqyY8mmT71kR83aR7fGZsF2LCAv8KvlslbHyFKb51ZliWdeciHuLuvPF2-wMvVg7POb7p-mp7iL7Upk3u28s8QL_PpovJLLu4-nk-KS8yy4TsMiictapSBSkogUJwamuwwrKCCFmrJZVWcgtOWgWkEnluWC5zxlmtilwuDTtAp8-5m365dpV1voum1ZvYrE3c6mAa_fHim5W-C48aiMqFEHxIOHlJiOGhd6nT6yZZ17bGu9AnTdXQTAolikGqnqU2hpSiq9_-ANH_QelPoPQASj-BGrxH74u-OV_JsH_f5ZLZ |
Cites_doi | 10.1161/HYP.0000000000000087 10.1186/s12905-021-01524-w 10.1161/JAHA.120.018604 10.1161/CIR.0b013e31820faaf8 10.1186/s13098-015-0085-5 10.3389/fcvm.2019.00160 10.1089/jwh.2018.7523 10.1111/1471-0528.15394 10.1210/clinem/dgab223 10.1016/j.preghy.2019.08.088 10.1016/j.atherosclerosis.2015.01.027 10.1016/j.preghy.2018.05.004 10.1161/HYPERTENSIONAHA.120.17101 10.1161/JAHA.122.028116 10.1016/j.preghy.2016.08.241 10.1161/CIRCULATIONAHA.118.038080 10.1093/eurheartj/ehy339 10.1016/j.preghy.2020.07.001 10.1371/journal.pmed.1002875 10.1161/HYPERTENSIONAHA.120.14971 10.1016/j.jacc.2017.11.006 10.1111/1471-0528.17381 10.1161/HYPERTENSIONAHA.120.15875 10.1007/s12020-016-1075-6 10.1177/2047487319879791 10.1097/AOG.0000000000002633 10.1161/HYPERTENSIONAHA.111.176537 10.1016/j.atherosclerosis.2019.11.023 10.1016/j.preghy.2021.09.008 10.1161/CIRCOUTCOMES.116.003497 10.1016/j.preghy.2021.10.004 10.1136/heartjnl-2020-316541 10.1136/bmj.i2416 10.1136/bmj.39335.385301.BE |
ContentType | Journal Article |
Copyright | 2024 The Authors. 2024 |
Copyright_xml | – notice: 2024 The Authors. 2024 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1161/HYPERTENSIONAHA.123.21890 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 860 |
ExternalDocumentID | 10_1161_HYPERTENSIONAHA_123_21890 38288610 |
Genre | Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABQRW ABVCZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJIOK AJNWD AJNYG AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CGR CS3 CUY CVF DIK DIWNM DUNZO E.X E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A NPM N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RHF RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c368t-17ecc9d97072017642cf1c6c37068f9b28c84c1e8c910d655a3585343f9758ba3 |
ISSN | 0194-911X |
IngestDate | Tue Sep 17 21:29:03 EDT 2024 Sat Oct 26 06:08:39 EDT 2024 Fri Aug 23 01:28:02 EDT 2024 Tue Oct 29 09:18:11 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | risk factors pre-eclampsia cardiovascular diseases postpartum period hypertension longitudinal studies |
Language | English |
License | Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c368t-17ecc9d97072017642cf1c6c37068f9b28c84c1e8c910d655a3585343f9758ba3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-4759-9407 0000-0003-0579-1975 0000-0002-7351-8922 0000-0003-2339-3751 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC10956664 |
PMID | 38288610 |
PQID | 2920186967 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10956664 proquest_miscellaneous_2920186967 crossref_primary_10_1161_HYPERTENSIONAHA_123_21890 pubmed_primary_38288610 |
PublicationCentury | 2000 |
PublicationDate | 2024-04-01 |
PublicationDateYYYYMMDD | 2024-04-01 |
PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hagerstown, MD |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2024 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_13_2 e_1_3_3_12_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_17_2 doi: 10.1161/HYP.0000000000000087 – ident: e_1_3_3_29_2 doi: 10.1186/s12905-021-01524-w – ident: e_1_3_3_13_2 doi: 10.1161/JAHA.120.018604 – ident: e_1_3_3_22_2 doi: 10.1161/CIR.0b013e31820faaf8 – ident: e_1_3_3_18_2 doi: 10.1186/s13098-015-0085-5 – ident: e_1_3_3_30_2 doi: 10.3389/fcvm.2019.00160 – ident: e_1_3_3_31_2 doi: 10.1089/jwh.2018.7523 – ident: e_1_3_3_9_2 doi: 10.1111/1471-0528.15394 – ident: e_1_3_3_14_2 doi: 10.1210/clinem/dgab223 – ident: e_1_3_3_26_2 doi: 10.1016/j.preghy.2019.08.088 – ident: e_1_3_3_8_2 doi: 10.1016/j.atherosclerosis.2015.01.027 – ident: e_1_3_3_15_2 doi: 10.1016/j.preghy.2018.05.004 – ident: e_1_3_3_34_2 doi: 10.1161/HYPERTENSIONAHA.120.17101 – ident: e_1_3_3_27_2 doi: 10.1161/JAHA.122.028116 – ident: e_1_3_3_12_2 doi: 10.1016/j.preghy.2016.08.241 – ident: e_1_3_3_5_2 doi: 10.1161/CIRCULATIONAHA.118.038080 – ident: e_1_3_3_20_2 doi: 10.1093/eurheartj/ehy339 – ident: e_1_3_3_33_2 doi: 10.1016/j.preghy.2020.07.001 – ident: e_1_3_3_4_2 doi: 10.1371/journal.pmed.1002875 – ident: e_1_3_3_28_2 doi: 10.1161/HYPERTENSIONAHA.120.14971 – ident: e_1_3_3_19_2 doi: 10.1016/j.jacc.2017.11.006 – ident: e_1_3_3_32_2 doi: 10.1111/1471-0528.17381 – ident: e_1_3_3_35_2 doi: 10.1161/HYPERTENSIONAHA.120.15875 – ident: e_1_3_3_7_2 doi: 10.1007/s12020-016-1075-6 – ident: e_1_3_3_10_2 doi: 10.1177/2047487319879791 – ident: e_1_3_3_23_2 doi: 10.1097/AOG.0000000000002633 – ident: e_1_3_3_24_2 doi: 10.1161/HYPERTENSIONAHA.111.176537 – ident: e_1_3_3_25_2 doi: 10.1016/j.atherosclerosis.2019.11.023 – ident: e_1_3_3_2_2 doi: 10.1016/j.preghy.2021.09.008 – ident: e_1_3_3_3_2 doi: 10.1161/CIRCOUTCOMES.116.003497 – ident: e_1_3_3_16_2 doi: 10.1016/j.preghy.2021.10.004 – ident: e_1_3_3_6_2 doi: 10.1136/heartjnl-2020-316541 – ident: e_1_3_3_11_2 doi: 10.1136/bmj.i2416 – ident: e_1_3_3_21_2 doi: 10.1136/bmj.39335.385301.BE |
SSID | ssj0014447 |
Score | 2.499269 |
Snippet | Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study... BACKGROUND: Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum.... BACKGROUNDIncreased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 851 |
SubjectTerms | Blood Pressure - physiology Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Cross-Sectional Studies Female Heart Disease Risk Factors Humans Hypertension - diagnosis Original Pre-Eclampsia - diagnosis Pre-Eclampsia - epidemiology Pregnancy Risk Factors |
Title | Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38288610 https://search.proquest.com/docview/2920186967 https://pubmed.ncbi.nlm.nih.gov/PMC10956664 |
Volume | 81 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIlVcEG_CS1uJm-UQe9frXW4RtLKAVAG1Unqy7PW67QGnykOi_DX-HDPrjWMnVEAvVmRbK8fzeV77zQwhb6NhUYpcKKzoySFAybmvuDK-ycsg42Uescx2-zwWySn_NI2mvd6vFmtptcwH-ucf60puI1U4B3LFKtn_kGyzKJyA3yBfOIKE4fhPMp7MjdEg0qvFZeavXzSmbLsk029IHz9yg3UEfsbLi7o1c-idAdIX3shOCoflzrH_xvWaijHhlmfY2flNIHCdW9q7xY38iJn4mmtkfgy8QMWqlV1oaiBG37NW8D_OqvNZKye_2fZBnre98OUaLIA3HuzkC7C6yBsN2umKsM1ycRlMxVHDTmsD5LQu3AeeHGurZRm04MdbOla6DrXOXNfjCHYtgUBLkJxNDiEuOEbDNEow88sG4NTUE0q73be3rGLDVbRRkgjSraVSWCq1S90hd0PQcsgn_Px1s4XFOXe1-vX_3ScH7rne3fhUXedoJ-LZJu62PKGTB-S-C2HoqMbjQ9Iz1SOyP3YkjcekvAGWtAtLirCkDpZU0BqWFGBCQ2phSS0saQPL9xRASSecWlA-IadHhycfEt-N8_A1E3LpBzGoC1WoeBiD1xlD4KvLQAvN4qGQpcpDqSXXgZEaXNhCRFHGIJZlnJUKgto8Y0_JXjWrzHNCjYkxmVLGBbinpZJYf10MNcQOrGBK6z4J1-8xvaq7tqR_lWOfHKzfeAo6FjfOssrMVosUJ7rh6DYR98mzWgLNskyGUkIM0ieyI5vmBuzf3r1SXV7YPu4BNgEVgr-4zdO-JPc2n9crsrecr8xr8I-X-RuLw9_6KrQI |
link.rule.ids | 230,315,783,787,888,27938,27939 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preeclampsia-Associated+Cardiovascular+Risk+Factors+6+Months+and+2+Years+After+Pregnancy%3A+The+P4+Study&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Henry%2C+Amanda&rft.au=Mangos%2C+George&rft.au=Roberts%2C+Lynne+M.&rft.au=Brown%2C+Mark+A.&rft.date=2024-04-01&rft.issn=0194-911X&rft.eissn=1524-4563&rft.volume=81&rft.issue=4&rft.spage=851&rft.epage=860&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.123.21890&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_HYPERTENSIONAHA_123_21890 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |